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Abstract. 
 
The Dowling-Meara variant of epidermolysis
bullosa simplex (EBS-DM) is a severe blistering disease
inherited in an autosomal-dominant fashion. Here we
report the generation of a mouse model that allows fo-
cal activation of a mutant keratin 14 allele in epidermal
stem cells upon topical administration of an inducer, re-
sulting in EBS phenotypes in treated areas. Using laser
capture microdissection, we show that induced blisters
healed by migration of surrounding nonphenotypic
stem cells into the wound bed. This observation pro-
vides an explanation for the lack of mosaic forms of
EBS-DM. In addition, we show that decreased mutant
keratin 14 expression resulted in normal morphology
and functions of the skin. Our results have important
implications for gene therapy of EBS and other domi-
nantly inherited diseases.
Key words: epidermolysis bullosa simplex • gene ther-
apy • gene targeting • epidermal stem cells • keratins
 
Introduction
 
The primary function of the epidermis is to provide a pro-
tective barrier for the internal tissues and organs. The
structural integrity of epidermal keratinocytes is main-
tained by a filamentous network made up of keratins,
which belong to the intermediate filament (IF)
 
1
 
 protein
superfamily (Moll et al., 1982; Quinlan et al., 1985). Two
types of keratin subunits have been described. In general,
type I keratin subunits are smaller, with an acidic pI, and
are encoded by genes located on chromosome 17 (Quinlan
et al., 1985). Type II keratin subunits are larger and more
basic, and are encoded by genes located on chromosome
12 (Quinlan et al., 1985).
The basic structure of keratins is an 
 
a
 
-helical rod do-
main made up of repeating units of seven amino acids.
One member of each type of keratins is needed to form a
heterodimer through the rod domain, which then assem-
bles into higher order structures to form mature keratin
filaments (Hatzfeld and Weber, 1990; Steinert, 1990;
Rothnagel and Roop, 1995). The 
 
a
 
-helical rod domain is
not continuous but is made up of four helical segments,
termed 1A, 1B, 2A, and 2B (Steinert and Roop, 1988).
The beginning of 1A and the end of 2B overlap with the
neighboring keratin molecules and are crucial for the sta-
bility of the keratin filaments (Rothnagel and Roop,
1995). Mutations in these regions of keratin genes have
been identified in patients with epidermolysis bullosa sim-
plex (EBS) and epidermolytic hyperkeratosis (EHK)
(Rothnagel and Roop, 1995).
The Dowling-Meara variant of EBS (EBS-DM, or EB
Herpetiformis, MIM No. 131760) is the most severe form
of EBS, and it is inherited in an autosomal-dominant fash-
ion. At birth, it presents with generalized blisters in areas
prone to mechanical trauma (Dowling and Meara, 1954;
Marinkovich et al., 1999). The underlying mechanism of
basal cell lysis is the disintegration of the IF network and
the formation of perinuclear keratin clumps (Anton-Lam-
precht and Schnyder, 1982; McGrath et al., 1992). EBS-
DM has been linked to chromosomes 12 and 17, and
mutations in keratin 5 (K5) and keratin 14 (K14) genes ex-
pressed in basal keratinocytes have been identified in
these patients (Letai et al., 1993; Chen et al., 1995; Roth-
nagel and Roop, 1995). In addition, a mutational “hot
spot” at codon 125 resulting in the change of an arginine in
the 1A region of the K14 rod domain was found in 70% of
EBS-DM patients (Rothnagel and Roop, 1995).
Two mouse models were previously generated for EBS
(Vassar et al., 1991; Lloyd et al., 1995). Both exhibited
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EBS-like phenotypes, but neither mimicked the domi-
nantly inherited disease at the genetic level. To test gene
therapy approaches for EBS, it is necessary to generate a
mouse model that mimics EBS at both the genetic and
phenotypic levels. In this study, we generated a mouse
model that fulfills these criteria. To elucidate the involve-
ment of epidermal stem cells, we also developed a mouse
model that allowed focal induction of EBS phenotypes.
 
Materials and Methods
 
Construction of the Targeting Vector
 
A genomic clone containing the mouse K14 gene in bacterial phage P1
was isolated from a 129/SVJ genomic library (Incyte Genomics). A C
 
®
 
T
point mutation at codon 131 (resulting in an arginine to cysteine substitu-
tion) in mouse K14 was engineered in a 1.3-kb BamHI fragment by PCR,
which was then used to replace the wild-type BamHI fragment in the
gene. For the selection of recombinant embryonic stem (ES) cells, a neo-
mycin-resistance (neo) cassette flanked by loxP sites (a gift from R.R. Beh-
ringer and Y. Mishina, University of Texas, M.D. Anderson Cancer Cen-
ter, Houston, TX) was inserted into the PmlI site in intron I of the mutant
K14 gene. This insertion also introduced an EcoRV restriction site that al-
lowed us to identify homologous recombination by Southern blot analysis.
 
Generation of mtK14
 
neo
 
 and mtK14
 
loxP
 
 Mice
 
Mouse 129/SVJ ES cells (Incyte Genomics) were electroporated with the
linearized targeting vector, and homologous recombination in ES cell
clones was identified by Southern blot analysis of genomic DNA digested
with Eco RV. The presence of the C
 
®
 
T mutation was confirmed by se-
quence analysis. Recombinant ES cells (mtK14
 
neo
 
) were injected into
C57BL/6 blastocysts. Three independent mtK14
 
neo
 
 mouse lines were gen-
erated, and were phenotypically indistinguishable. The mtK14
 
neo
 
 ES cells
were also transfected with a CMV-Cre plasmid (a gift from S. O’Gorman,
The Salk Institute for Biological Studies, San Diego, CA), and cells with-
out the neo cassette (mtK14
 
loxP
 
) were injected into blastocysts as well.
 
RNA Preparation and Semi-quantitative
RT-PCR Analysis
 
Total RNA from newborn pup epidermis was isolated using RNAzol B
(Tel-Test). Equal amounts of total RNA from epidermal samples were re-
verse transcribed into cDNA. The cDNA was amplified by semi-quanti-
tative PCR using K14-specific primers: 5
 
9
 
-CTAGCCGCATGTCCT-
CCATC-3
 
9
 
 and 5
 
9
 
-biotin-CCGAATCTTCACCTCCAGTTC-3
 
9
 
. PCR
products were gel purified and digested with AciI (New England Biolabs,
Inc.). Digestion of the wild-type PCR products yielded a 71-bp biotin-
ylated fragment. The C
 
®
 
T mutation destroyed an AciI site, resulting in a
136-bp biotinylated fragment from the mutant PCR products. Digested
DNA fragments were separated by gel electrophoresis, blotted onto
GeneScreenPlus membrane (New England Biolabs, Inc.), and detected
with BrightStar BioDetect kit (Ambion). The intensity of the signals was
determined by QuantiScan software (Biosoft).
 
Immunofluorescence Microscopy and Transmission 
Electron Microscopy
 
Biopsied skin was fixed in 10% Formalin (Fisher Scientific) or embedded
in OCT (Sakura Finetek USA), and indirect immunofluorescent staining
of sections was performed as previously described (Wojcik et al., 2000),
using a guinea pig anti-K14 antibody, a rabbit anti-K10 antibody, a rabbit
anti-loricrin antibody, and a rat anti-integrin 
 
a
 
6 antibody (Chemicon)
(Wang et al., 1995). The anti-K14 antibody recognized both wild-type and
mutant mouse K14. Transmission electron microscopy was carried out fol-
lowing standard protocol (Wang et al., 1995).
 
Laser Capture Microdissection
 
Biopsied skin from healed blistered area on the palm of RU486 treated
mtK14
 
neo
 
/CrePR1 pups was fixed in 10% Formalin and embedded in par-
affin (Wojcik et al., 2000). Paraffin slides were stained with Nuclear Fast
Red (Vector Laboratories), and epidermal cells under the scab were
 
transferred onto a thermoplastic polymer film (CapSure™)
 
 
 
by a near in-
frared laser pulse on a PixCell I microscope/laser capture equipment
(Arcturus Engineering). Genomic DNA was extracted from cells attached
to the film in 10 mM Tris-HCl (pH 8.0), 0.2 mM EDTA (pH 8.0), 0.25%
Tween 20, and 0.5% Nonidet P-40 containing 1 mg/ml proteinase K. DNA
was then analyzed by PCR. For the presence of the loxP site, primers 5
 
9
 
-
GAACTGGAGGTGAAGATTCG-3
 
9
 
 (in exon I of K14) and 5
 
9
 
-GGGT-
TATTGAATATGATCGG-3
 
9
 
 (in the loxP site) were used. For the pres-
ence of the neo cassette, primers 5
 
9
 
-GCGGAACCCTTAATATAACT-3
 
9
 
(in the linker region of the neo cassette) and 5
 
9
 
-CCACACAGTCAGCT-
TCAACC-3
 
9
 
 (in intron I of K14) were used.
 
Results and Discussion
 
Characterization of mtK14
 
neo
 
 Mice
 
To generate a mouse model that mimics EBS-DM at the
genetic level, we introduced a point mutation in codon 131
(equivalent to arginine 125 in human K14) of the mouse
K14 gene. The gene targeting vector used to introduce this
mutation into ES cells also contained a neo cassette in in-
tron I (Fig. 1 A). The linearized targeting vector was elec-
Figure 1. Targeting strategy and Southern blot analysis. (A) Tar-
geting strategy. Open boxes represent the exons. The asterisk de-
notes the C®T point mutation, and neo denotes the neomycin-
resistance selection cassette. (B) Southern blot analysis of
EcoRV-digested genomic DNA. The 59 external probe (A) hy-
bridized to an 11.7-kb fragment from the wild-type K14 locus,
and a 5.5-kb fragment from the mtK14neo locus. The 39 external
probe (A) hybridized to the same 11.7-kb fragment from the
wild-type K14 locus, and an 8.0-kb fragment from the mtK14neo
locus. het., heterozygote;  homo., homozygote. 
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troporated into ES cells, and homologous recombination
was identified by Southern blot analysis of genomic DNA
from these cells (Fig. 1 B). The presence of the point muta-
tion was confirmed by sequence analysis (data not shown).
Correctly targeted ES cells bearing the point mutation
were injected into mouse blastocysts, and heterozygous
mtK14
 
neo
 
 (
 
1
 
/mtK14
 
neo
 
) mice were derived. These mice ap-
peared normal with no gross skin phenotypes, and histologi-
cal analysis did not show microscopic blisters (data not
shown). This was unexpected as the equivalent mutation in
humans results in a dominantly inherited disease. We hy-
pothesized that the lack of a phenotype in these mice was
due to an interference of the neo cassette with the expression
of the mutant K14 gene. This hypothesis was supported by
semi-quantitative RT-PCR analysis that showed a twofold
lower expression of mtK14
 
neo
 
 than wild-type K14 (Fig. 2 F).
Homozygous mtK14
 
neo
 
 pups were normal at birth. How-
ever, within hours after birth, they developed extensive
blisters on the front legs, paws, and chest (Fig. 2 A), and
usually died within 48 h. Histological analysis indicated a
separation within the basal cell layer of the epidermis (Fig.
 
2 B), which was confirmed by indirect immunofluorescent
staining of K14 and integrin 
 
a
 
6, showing an intact base-
ment membrane (Fig. 2, C and D). These results suggest
that the separation occurred due to cytolysis of basal kera-
tinocytes. Immunofluorescence microscopy using various
differentiation markers such as keratin 10 (Fig. 2 E) and
loricrin (data not shown) did not indicate any changes in
the differentiation of the epidermis. Transmission electron
microscopy revealed keratin clumps in the basal kerati-
nocytes of lesional areas (data not shown). Primary kerati-
nocytes isolated from homozygous mtK14
 
neo
 
 pups showed
a collapsed perinuclear IF network and cytoplasmic kera-
tin aggregates when subjected to heat shock, whereas a
normal IF network remained in wild-type keratinocytes
under identical conditions (data not shown). These results
are consistent with observations made in EBS-DM pa-
tients and their cultured keratinocytes (Coulombe, 1993;
Morley et al., 1995; Marinkovich et al., 1999).
Like the previously reported K14 null mice (Lloyd et al.,
1995), the homozygous mtK14
 
neo
 
 pups resembled a re-
cessive form of EBS (Chan et al., 1994; Rugg et al.,
1994; Jonkman et al., 1996). However, the homozygous
mtK14
 
neo
 
 pups exhibited a more severe phenotype. Al-
though some K14 null mice lived for as long as 3 mo pre-
sumably due to functional compensation by keratin 15
(Lloyd et al., 1995), more than 95% of the homozygous
mtK14
 
neo
 
 pups died within 48 h after birth, and none lived
beyond 5 d. This more severe phenotype is likely due to
the significant amount of mutant K14 in these mice (Fig. 2,
C and F). We suspect that mutant K14 competed with the
low level of keratin 15 in newborn pups for dimerization
with K5, resulting in the absence of functional keratin fila-
ments in the basal layer.
 
Characterization of mtK14
 
loxP
 
 Mice
 
To unequivocally demonstrate that the low expression
level of the mutant K14 allele led to the absence of a phe-
notype in 
 
1
 
/mtK14
 
neo
 
 mice, we deleted the neo cassette in
mtK14
 
neo
 
 ES cell clones via Cre-mediated excision (Fig. 1
A). Heterozygous mtK14
 
loxP
 
 (
 
1
 
/mtK14
 
loxP
 
) pups derived
from these ES cells spontaneously developed large blisters
on their forelimbs and trunk (Fig. 3 A), as expected for
this dominant mutation. Semi-quantitative RT-PCR anal-
ysis of RNA isolated from these pups showed comparable
expression levels of the mutant and wild-type K14 alleles
(Fig. 2 F). Histological analysis and immunofluorescence
microscopy revealed similar findings as in the homozygous
mtK14
 
neo
 
 pups (data not shown).
An important diagnostic feature of EBS-DM is the
collapsed IF filaments revealed upon ultrastructural
examination (Anton-Lamprecht and Schnyder, 1982;
Marinkovich et al., 1999). Transmission electron mi-
croscopy showed keratin clumps in the basal kerati-
nocytes of 
 
1
 
/mtK14
 
loxP
 
 pups (Fig. 3, B, E, and F). Short
IF filaments were also observed in basal keratinocytes
(Fig. 3, E and G), probably due to the significant
amount of wild-type K14. In contrast, long IF filaments
were observed in the basal keratinocytes in wild-type
littermates (Fig. 3 D). The keratin clumps and short fila-
ments were sometimes attached to desmosomes or
hemidesmosomes, or in the perinuclear space (Fig. 3,
Figure 2. Phenotype of homozygous mtK14neo pups. (A) Gross
phenotype of a 1-d-old pup, showing severe blisters on the front
legs, paws, and chest. (B) H&E staining of skin from a homozy-
gous mtK14neo pup. The separation occurred in the basal cell
layer within the epidermis. (C–E) Immunofluorescence micros-
copy of pup skin. The sections were stained for mutant K14
(Texas red, C–E), integrin a6 (FITC, D), and keratin 10 (FITC,
E). Overlapping of K14 staining with either integrin a6 (D) or
keratin 10 (E) results in yellow fluorescence. (F) AciI digestion
of semi-quantitative RT-PCR products from mouse RNA. (1)
Wild type; (2) homozygous mtK14neo; (3 and 4) 1/mtK14neo; (5)
1/mtK14loxP. Note the lower expression levels of mtK14neo allele
in 1/mtK14neo mice shown in lanes 3 and 4. 
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E–G). Some basal cells of the mutant were vacuolated,
and in the blistering areas, lymphocyte infiltration was
observed (data not shown). The suprabasal kerati-
nocytes appeared normal, with abundant keratin bun-
dles and desmosomes in the spinous and granular cells
(Fig. 3 C). Unfortunately, 
 
1
 
/mtK14
 
loxP
 
 pups died within
a week after birth due to severe blistering.
 
An Inducible Mouse Model for EBS
 
It is important to note that although 
 
1
 
/mtK14
 
neo
 
 pups
appeared normal, 
 
1
 
/mtK14
 
loxP
 
 pups with increased mu-
tant K14 expression developed severe EBS-like pheno-
types. These observations suggested that we might be
able to generate a viable model for EBS if we could fo-
cally delete the neo cassette in 
 
1
 
/mtK14
 
neo
 
 mice.
Figure 3. Phenotype of 1/mtK14loxP pups. (A)
Gross phenotype of a 2-d-old pup, showing
blisters on the left front leg and abdomen.
(B–G) Transmission electron microscopy of
skin samples from 1/mtK14loxP pups (B, C,
and E–G) and normal littermate (D). The
mtK14loxP pup skin showed keratin clumps
and short keratin filaments in the basal kera-
tinocytes (B, E–G), but normal keratin fila-
ments in the suprabasal layer of the epider-
mis (B and C). Normal skin showed long
keratin filaments in the basal keratinocytes
(D). Kc, keratin clumps; Kf, keratin fila-
ments; Kg, keratohyalin granules; Nu, nu-
cleus. Small arrowheads denote hemides-
mosomes, indicating the position of the
basement membrane. Large arrowheads de-
note desmosomes. Bars: (B) 5 mm; (C) 100
nm; (D–G) 1 mm. 
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To achieve this goal, we exploited a recently developed
transgenic mouse model that allows focal deletion of ge-
nomic sequences upon topical application of an inducer
(Berton et al., 2000). This system uses tissue-specific ex-
pression of Cre-recombinase fused to a truncated proges-
terone receptor (PR1) (Kellendonk et al., 1996) under
the control of an epithelial-specific promoter, such as that
of K5 or K14 (Berton et al., 2000). PR1 does not bind
to endogenous progesterone, but binds to antiprogestin
(Kellendonk et al., 1996). In the absence of an antiproges-
tin, the CrePR1 fusion protein is expressed in the basal ke-
ratinocytes and hair follicles, but is retained in the cyto-
plasm and remains inactive. Upon topical administration
of an antiprogestin, such as RU486, CrePR1 translocates
to the nucleus and becomes active.
Mice carrying the CrePR1 transgene under the control
of a K5 or K14 promoter were bred with 
 
1
 
/mtK14
 
neo
 
 mice,
and bigenic pups (mtK14
 
neo
 
/CrePR1) were obtained.
RU486 (0.5 mg/ml in ethanol) was applied once daily to
the forelimbs and chest of newborn pups, areas prone to
mechanical trauma. After several (two to seven) days of
RU486 treatment, we observed blisters filled with fluid on
the front legs and paws of bigenic pups (Fig. 4 A). RU486
treatment was terminated once blisters became visible.
Histological analysis and immunofluorescence microscopy
revealed that blistering occurred within the basal layer of
the epidermis, as expected (Fig. 4, D and E).
PCR analysis of DNA isolated from keratinocytes in the
blister roof revealed the presence of the loxP site, but not
the neo cassette (Fig. 4, F and G). This result indicates that
activation of the CrePR1 fusion protein and the subse-
quent excision of the neo cassette can be efficiently
achieved with as few as two RU486 treatments. Upon ter-
mination of RU486 treatment, the induced blistered areas
healed without scarring in 2 wk (Fig. 4, B and C). No addi-
tional blisters formed without further RU486 treatment.
When we dissected the healed area 1 wk after blister for-
mation and extracted DNA from epidermal cells under
the scab, isolated by laser capture microdissection, the
presence of the neo cassette was detected (Fig. 4 G).
It is possible that CrePR1 was only activated in the non-
stem cell population of basal keratinocytes (transit ampli-
fying cells) in the blistered area. Although blisters were in-
duced through cytolysis of these cells, the stem cells were
not targeted, i.e., they retained the neo cassette and repop-
ulated the area after 7 d. However, this is not likely the
case based on observations in the accompanying manu-
script (Arin et al., 2001), where the same inducible system
was used to develop a mouse model for EHK. In the EHK
mouse model, lesions develop in the suprabasal kerati-
nocytes although the basal cells (including the stem cells)
remain normal. Unlike our EBS lesions, induced EHK le-
sions persist, to date for 6 mo. Because the normal turn-
over time for mouse epidermis is 
 
z
 
8–10 d (Potten et al.,
1987), this result clearly shows that epidermal stem cells
are targeted by our inducible system. Therefore, the pres-
ence of mtK14
 
neo
 
 allele in the healed area is best explained
by migration and reepithelialization by nonphenotypic
mtK14
 
neo
 
 stem cells or transit amplifying cells derived
from these stem cells from the untreated surrounding area.
Healing of the induced blisters and the absence of recur-
rent lesions have significant implications for gene therapy
of EBS, as defective stem cells may be replaced by non-
phenotypic stem cells.
Interestingly, although mosaic forms of EHK have been
described (Paller et al., 1994), a mosaic form of EBS has
never been reported. Mosaic forms of EHK probably arise
through postzygotic mutations, and the distribution of af-
fected epidermis reflects migration and proliferation of
mutant epidermal stem cells (Paller et al., 1994). To ex-
plain the absence of mosaic forms of EBS, it is tempting to
speculate that when postzygotic mutations occur in K5 or
K14, the epidermal stem cells carrying the mutation would
have a selective disadvantage and be rapidly displaced by
Figure 4. Induction and characterization of RU486 induced blis-
ters. (A) Gross phenotype of an induced blister on a mtK14neo/
CrePR1 pup after two RU486 treatments on the right front leg.
No blisters developed on the untreated leg (A) or in 1/mtK14neo
or CrePR1 control pups treated with RU486 (data not shown).
(B) The right front paw of a mtK14neo/CrePR1 pup 10 d after
blister formation upon treatment. (C) The left front paw and leg
of a mtK14neo/CrePR1 mouse 6 mo after blister formation and
cessation of RU486 treatment. The blistered area, including the
palm and leg, healed without scarring, and there is normal hair
growth on the leg. No additional blisters formed without further
RU486 treatment. (D and E) H&E staining (D) and immunoflu-
orescence microscopy with an anti-K14 antibody (Texas red, E)
of an induced blister edge. Blistering occurred in the basal kerati-
nocytes (arrowheads) on the chest (D and E), front leg, and paw
(data not shown). The asterisk denotes cytolysis, and dashed lines
outline the hair follicles. (F and G) PCR analysis of DNA for the
presence of the loxP site (F) and neo cassette (G). (1–3) Epidermal
DNA samples from different areas of a treated mtK14neo/CrePR1
pup. (1) Untreated area; (2) blister roof; (3) healed blistered area 1
wk after blister formation. (4–6) DNA samples from control mice.
(4) Wild type; (5) 1/mtK14loxP; (6) 1/mtK14neo. 
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wild-type stem cells. Consistent with the clinical observa-
tions, focal lesions were observed in chimeric EHK mice
derived from 
 
1
 
/mut
 
loxP
 
 ES cells (Arin et al., 2001), but not
in chimeric 
 
1
 
/mtK14
 
loxP
 
 mice.
Our inducible transgenic mouse model (mtK14
 
neo
 
/
CrePR1) allows focal induction of EBS phenotypes while
the mice remain viable. Thus, it is ideally suited to test
gene therapy approaches for EBS-DM in vivo. Chimeric
RNA–DNA oligonucleotides could be used to correct the
point mutation in the mutant K14 allele through homolo-
gous recombination and mismatch repair (Cole-Strauss et
al., 1996; Alexeev et al., 2000). Alternatively, the fact that
 
1
 
/mtK14
 
neo
 
 mice expressed low levels of mutant K14 but
had morphologically normal and functional skin suggests
that the EBS phenotype may be corrected by increasing
the ratio of wild-type versus mutant K14. This could be
achieved by either increasing the expression of the wild-
type K14 or partial suppression of the mutant K14 allele.
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